Coupang
CPNG
$13.78
-0.14%
Coupang, Inc. is South Korea's largest e-commerce platform, operating an integrated model that spans owned inventory, third-party merchant services, and a proprietary end-to-end logistics network capable of delivering orders placed seconds before midnight. Beyond core retail, the company has expanded into Rocket Fresh grocery delivery, Coupang Eats meal delivery, Taiwan e-commerce, luxury retail via Farfetch, and travel services, positioning itself as a diversified consumer platform rather than a pure-play retailer. The current investor narrative is dominated by a sharp deterioration in sentiment: the stock has fallen over 56% in the past year, with a data breach weighing on reputation, a swing to a quarterly net loss of $266 million in Q1 2026, and a broader market rotation away from unprofitable growth names. Bulls argue the selloff has created a generational entry point into a dominant platform with a 29.4% gross margin and a fortress-like $6.4 billion cash position, while bears point to decelerating revenue growth, margin compression, and the risk that competitive intensity in Korea erodes Coupang's structural advantages.…
CPNG
Coupang
$13.78
Related headlines
Investment Opinion: Should I buy CPNG Today?
The synthesized recommendation is Hold. The core thesis is that Coupang's dominant market position and deep value on sales multiples are offset by a sharp deterioration in profitability and negative free cash flow, creating a high-risk turnaround situation. The analyst consensus rating of Buy with an average target of $23.51 implies 69.4% upside, but the wide target range of $12.00 to $30.00 and the presence of Neutral ratings indicate low conviction and high uncertainty.
Supporting evidence for a Hold includes the stock's PS ratio of 1.24x, which is well below its historical range of 4.05x to 16.28x, suggesting deep value if margins recover. However, the forward PE of 50.95x and PEG of 7.60x are stretched, and the company's Q1 2026 net loss of $266 million and negative EBITDA of -$99 million highlight the earnings challenge. Revenue growth has decelerated to 7.54% year-over-year, and free cash flow is negative at -$112 million, while the balance sheet shows a current ratio of 1.04 and debt-to-equity of 1.00. The implied upside to the average analyst target is substantial, but the downside risk to the low target of $12.00 is 13.5%.
The biggest risks that could invalidate the thesis are a continued decline in revenue growth, further margin compression, and a failure to restore profitability. The rating would upgrade to Buy if the company demonstrates a return to positive net income and free cash flow, or if the stock price falls significantly below the analyst low target of $12.00 with improving fundamentals. It would downgrade to Sell if revenue growth turns negative, margins continue to compress, or the data breach leads to a permanent loss of market share. On valuation, the stock appears undervalued on sales multiples but overvalued on earnings-based metrics, making it a speculative value play rather than a clear buy.
Sign up to view all
CPNG 12-Month Price Forecast
Coupang presents a high-risk, high-reward turnaround story. The stock's 56% decline over the past year has created deep value on sales multiples, but the company's profitability has deteriorated sharply, with negative free cash flow and a net loss in Q1 2026. The analyst consensus remains bullish with a $23.51 average target, but the wide target range and recent downgrades suggest low conviction. The key tension is whether Coupang can restore margins and reaccelerate growth; if it does, the stock could double, but if it doesn't, further downside is likely. I would upgrade to bullish if Q2 2026 shows a return to positive EBITDA and free cash flow, and downgrade to bearish if revenue growth falls below 5% or if the data breach leads to significant customer losses.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coupang's 12-month outlook, with a consensus price target around $23.51 and implied upside of +70.6% versus the current price.
Average Target
$23.51
0 analysts
Implied Upside
+70.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$12 - $30
Analyst target range
Coupang is covered by 18 analysts, with a consensus recommendation of "Buy" and a recommendation mean of 1.72 (where 1 is Strong Buy and 5 is Strong Sell), indicating that the sell-side remains constructive despite the stock's collapse. The average target price is $23.51, which implies 69.4% upside from the current price of $13.88, a strikingly large gap that suggests analysts believe the market has overshot to the downside. However, the consensus is not uniformly bullish: the distribution includes Buy ratings from B of A Securities and Barclays (Overweight), but Citigroup downgraded to Neutral in May 2026 and Mizuho has maintained a Neutral stance, indicating that some analysts see limited near-term catalysts. The average EPS estimate of $0.55 for the forward year, against a trailing EPS of $0.00485, underscores the magnitude of the expected earnings recovery that underpins the bullish targets. The target range spans from a low of $12.00 to a high of $30.00, a spread of $18.00 or 150% of the current price, which signals unusually high uncertainty and disagreement among analysts about Coupang's trajectory. The high target of $30.00 implies a market cap of roughly $54.8 billion and assumes a successful turnaround in margins, a resolution of the data breach overhang, and a reacceleration of revenue growth, potentially driven by Taiwan expansion or Farfetch synergies. The low target of $12.00, which is 13.5% below the current price, prices in continued margin compression, competitive share loss in Korea, and the possibility that the company remains unprofitable through 2027. The institutional ratings history shows a mix of reiterations and one downgrade (Citigroup from Buy to Neutral in May 2026), with no recent upgrades, suggesting that the sell-side is in a wait-and-see mode and that the burden of proof is on management to deliver a credible path back to profitability. The wide target spread and the presence of Neutral ratings indicate that conviction is low, and the stock is likely to remain volatile until there is clearer evidence of a fundamental inflection.
Bulls vs Bears: CPNG Investment Factors
The bear case currently has stronger evidence, as the company's fundamental deterioration is concrete and recent: a swing to a $266 million net loss, negative EBITDA, negative free cash flow, and decelerating revenue growth. The bull case rests largely on the stock's depressed valuation and analyst targets that assume a sharp earnings recovery, but those targets have not been revised upward and some analysts have downgraded to Neutral. The single most important tension is whether Coupang can restore profitability and reaccelerate growth in the face of rising fulfillment costs and competitive pressure in Korea. If margins recover, the stock could re-rate sharply; if they do not, the current valuation on earnings remains unsupportable and further downside is likely.
Bullish
- Analyst consensus sees 69% upside: 18 analysts cover CPNG with a consensus recommendation of 'Buy' (mean 1.72) and an average target price of $23.51, implying 69.4% upside from the current $13.88. Even the lowest target of $12.00 is only 13.5% below the current price, suggesting the sell-side views the selloff as overdone.
- Deep value on sales multiples: CPNG trades at a PS ratio of 1.24x and EV/Sales of 0.69x, dramatically below its historical PS range of 4.05x to 16.28x. With $34 billion in annualized revenue and a $6.4 billion cash position, the market is pricing in a severe permanent impairment that may not materialize.
- Dominant Korean e-commerce platform: Coupang is South Korea's largest e-commerce platform with an integrated logistics network covering the entire country, enabling midnight delivery. This structural moat supports a 29.4% gross margin and makes it difficult for competitors to replicate its service level.
- Fortress balance sheet with $6.4B cash: Cash at the end of Q1 2026 was $6.391 billion, providing substantial runway to fund investments in Taiwan, Farfetch, and Coupang Eats without immediate solvency risk. Debt-to-equity of 1.00 is manageable for a company with this cash cushion.
Bearish
- Revenue growth decelerating sharply: Q1 2026 revenue grew only 7.54% year-over-year to $8.504 billion, a steep slowdown from prior double-digit growth. Sequential revenue has declined from $9.267 billion in Q3 2025 to $8.504 billion in Q1 2026, signaling underlying softness.
- Profitability collapsed to net loss: Q1 2026 net income was -$266 million with a net margin of -3.13%, a dramatic reversal from +$107 million and +1.35% in Q1 2025. EBITDA turned negative at -$99 million, and operating margin swung from +1.95% to -2.85%.
- Negative free cash flow and rising leverage: Free cash flow turned negative at -$112 million in Q1 2026 versus +$115 million a year earlier, while debt-to-equity stands at 1.00 and the current ratio is a thin 1.04. Cash declined from $7.324 billion in Q3 2025 to $6.391 billion in Q1 2026.
- Extreme relative weakness and downtrend: CPNG has fallen 56.42% over the past year and 40.61% year-to-date, with a 1-month decline of 16.03% and 3-month decline of 21.05%. Relative strength versus SPY is -73.64 percentage points over 1 year, indicating a severe stock-specific derating.
CPNG Technical Analysis
Coupang is in a sustained and severe downtrend, with the 1-year price change of -56.42% and a 6-month decline of -23.27% confirming persistent selling pressure. At the current price of $13.88, the stock is trading at just 0.1% above its 52-week low of $13.86 and only 42.1% of its 52-week high of $32.96, meaning it sits essentially at the bottom of its annual range. This positioning signals that momentum remains firmly negative and that buyers have yet to establish any meaningful floor; while such extreme weakness can attract value-oriented accumulation, the absence of a bounce off the low suggests the market is still searching for a capitulation point rather than forming a base. Recent momentum has been unrelentingly negative, with a 1-month decline of -16.03% and a 3-month decline of -21.05%, both worse than the longer-term trend and indicating acceleration to the downside rather than stabilization. The 1-month relative strength versus SPY of -16.72 percentage points and the 3-month relative strength of -26.86 percentage points highlight that this is not a market-wide phenomenon but a stock-specific derating, likely tied to the Q1 2026 earnings miss and reputational overhang. The short ratio of 5.02 suggests that short sellers have built a meaningful position, which could fuel a sharp squeeze on any positive catalyst, but it also confirms that institutional sentiment remains deeply bearish and that rallies are likely to be sold until the fundamental narrative improves. Key technical levels are starkly defined: the 52-week low at $13.86 is the immediate support, and a breakdown below that level would likely trigger momentum-driven selling and open the door to price discovery to the downside, while the 52-week high at $32.96 represents a distant resistance that would require a complete reversal of the current narrative to challenge. The stock's beta of 1.152 means it is approximately 15.2% more volatile than the broader market, which, combined with a maximum drawdown of -58.6%, underscores the importance of disciplined position sizing; a beta above 1 in a downtrend amplifies losses, and the current price sitting just $0.02 above the 52-week low means even a modest market pullback could push the stock to new lows.
Beta
1.15
1.15x market volatility
Max Drawdown
-59.0%
Largest decline past year
52-Week Range
$13-$33
Price range past year
Annual Return
-57.7%
Cumulative gain past year
| Period | CPNG Return | S&P 500 |
|---|---|---|
| 1m | -13.7% | +0.6% |
| 3m | -25.8% | +3.3% |
| 6m | -27.3% | +17.4% |
| 1y | -57.7% | +15.0% |
| ytd | -41.0% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CPNG Fundamental Analysis
Coupang's revenue trajectory is showing clear deceleration, with Q1 2026 revenue of $8.504 billion representing 7.54% year-over-year growth, a sharp slowdown from the double-digit pace the company sustained through much of 2024 and early 2025. The sequential trend is also concerning: revenue declined from $9.267 billion in Q3 2025 to $8.835 billion in Q4 2025 and further to $8.504 billion in Q1 2026, reflecting both seasonality and underlying softness. Segment data shows that Product revenue of $6.476 billion remains the dominant driver, while Third-Party Merchant Services contributed $1.767 billion and Service/Other added $261 million, indicating that the core owned-inventory model still carries the bulk of the growth burden. The deceleration implies that Coupang is transitioning from a high-growth disruptor to a more mature retailer, which compresses the multiple the market is willing to pay and raises the bar for profitability improvements to justify the valuation. Profitability has deteriorated sharply, with Q1 2026 net income of -$266 million and a net margin of -3.13%, a dramatic reversal from the $107 million profit and 1.35% net margin in Q1 2025. Gross margin has compressed from 29.29% in Q1 2025 to 27.01% in Q1 2026, while operating margin swung from +1.95% to -2.85%, and EBITDA turned negative at -$99 million versus +$361 million a year earlier. The compression appears driven by rising fulfillment costs, continued investment in Taiwan and Farfetch, and the absence of operating leverage as revenue growth slows; for a specialty retailer, a 27% gross margin is respectable but the negative operating margin is well below what the market expects from a scaled platform, and the trajectory is moving in the wrong direction. The balance sheet offers some cushion but also reveals stress: debt-to-equity stands at 1.00, the current ratio is a thin 1.04, and free cash flow turned negative at -$112 million in Q1 2026 versus +$115 million in Q1 2025. Cash at the end of Q1 2026 was $6.391 billion, down from $7.324 billion in Q3 2025, reflecting $296 million in capital expenditures, $391 million in stock repurchases, and $738 million in debt repayment. ROE has collapsed to 4.50% and ROA is negative at -2.14%, indicating that the company is not generating adequate returns on its invested capital; while the cash pile provides runway, the negative FCF and rising leverage suggest that Coupang may need to moderate its investment pace or accept further balance sheet deterioration if the operating environment does not improve.
Quarterly Revenue
$8.9B
2026-06
Revenue YoY Growth
+3.9%
YoY Comparison
Gross Margin
28.2%
Latest Quarter
Free Cash Flow
$107537140.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CPNG Overvalued?
Because Coupang's trailing net income is marginally positive at $0.00485 per share, the trailing PE ratio of 214.45x is technically applicable but economically meaningless, so the more informative metric is the forward PE of 50.95x, which reflects the market's expectation of a sharp earnings recovery. The gap between the trailing PE of 214.45x and the forward PE of 50.95x implies that analysts expect earnings to roughly quadruple over the next twelve months, a highly optimistic assumption given the Q1 2026 net loss of $266 million and the negative EBITDA of -$99 million. The PS ratio of 1.24x and EV/Sales of 0.69x provide a more grounded view, suggesting that the market is valuing Coupang at a modest premium to sales despite the earnings collapse, which is consistent with a company that still generates $34 billion in annualized revenue. Compared to the specialty retail industry, Coupang's PS ratio of 1.24x is not obviously expensive, but its forward PE of 50.95x is well above the sector average, which typically ranges in the mid-to-high teens for mature retailers. The PEG ratio of 7.60x signals that the market is paying a steep price for expected growth, and the EV/EBITDA of 34.34x is elevated for a retailer with negative EBITDA in the most recent quarter. The premium is difficult to justify on current fundamentals; it rests entirely on the assumption that Coupang can restore profitability and reaccelerate growth, and any further disappointment would likely compress the multiple toward the sector average, implying significant downside. Historically, Coupang's PS ratio has ranged from a high of 16.28x in Q2 2021 to a low of 4.05x in Q1 2026, and the current PS of 1.24x is dramatically below that historical band, reflecting the severity of the derating. However, the historical PS data is based on a different share count and price environment, and the current PS of 1.24x is calculated on a market cap of $42.9 billion against trailing revenue, which is a more conservative measure. The stock's PB ratio of 9.28x remains elevated relative to the historical range of 7.06x to 26.01x, suggesting that book value has not kept pace with the price decline and that the market is still assigning a premium to Coupang's asset base. The key takeaway is that while the PS ratio looks cheap relative to history, the earnings-based multiples are stretched, creating a valuation picture that is highly dependent on the path of profitability; if margins do not recover, the stock could continue to derate.
PE
214.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~161x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
34.3x
Enterprise Value Multiple
Investment Risk Disclosure
Coupang faces significant financial and operational risks. The company swung to a net loss of $266 million in Q1 2026 from a $107 million profit a year earlier, with EBITDA turning negative at -$99 million and free cash flow at -$112 million. Gross margin compressed from 29.29% to 27.01% year-over-year, and operating margin fell from +1.95% to -2.85%, indicating that cost pressures are eroding profitability. The balance sheet shows debt-to-equity of 1.00 and a current ratio of just 1.04, leaving little room for error if losses continue. Cash declined by $933 million from Q3 2025 to Q1 2026 due to capital expenditures, stock repurchases, and debt repayment, and further cash burn could strain liquidity.
Market and competitive risks are acute. The stock trades at a forward PE of 50.95x and a PEG of 7.60x, well above the specialty retail sector average, leaving it vulnerable to multiple compression if earnings disappoint. The data breach has damaged Coupang's reputation in South Korea, potentially accelerating customer churn and inviting regulatory scrutiny. Competition from Naver and other local players could pressure margins further, while the Taiwan and Farfetch expansions add execution risk. With a beta of 1.152, the stock is more volatile than the market, and its 1-year relative strength versus SPY is -73.64 percentage points, highlighting severe underperformance that could continue if sector rotation favors profitable growth.
The worst-case scenario involves a continued decline in revenue growth, further margin compression, and a failure to restore profitability, leading to a breakdown below the 52-week low of $13.86. If the stock breaches that level, momentum-driven selling could push it toward the analyst low target of $12.00, representing a 13.5% decline from the current price. In a more severe scenario where the company remains unprofitable through 2027 and the data breach triggers lasting market share loss, the stock could retest its historical maximum drawdown of -58.6%, implying a price near $5.75. From the current $13.88, that would represent a loss of approximately 58.6%, or $8.13 per share.
FAQ
The most severe risk is financial: Coupang swung to a net loss of $266 million in Q1 2026, with negative EBITDA of -$99 million and negative free cash flow of -$112 million. The balance sheet shows a current ratio of 1.04 and debt-to-equity of 1.00, leaving little cushion if losses continue. Competitive risk is also high, as Naver and other Korean players could pressure margins and market share, while the data breach has damaged Coupang's reputation and could invite regulatory action. Macro risk includes the stock's beta of 1.152, making it more volatile than the market, and its 1-year relative strength versus SPY of -73.64 percentage points, indicating severe underperformance that could persist. Company-specific risk centers on the Taiwan and Farfetch expansions, which are unproven and could distract management from the core Korean business.
The 12-month forecast has three scenarios. The bull case (25% probability) targets $23.50 to $30.00, assuming a successful turnaround with positive net income and reaccelerated growth. The base case (50% probability) targets $16.00 to $20.00, with gradual margin recovery and mid-single-digit revenue growth. The bear case (25% probability) targets $12.00 to $13.86, reflecting continued losses and a breakdown below the 52-week low. The most likely scenario is the base case, which assumes revenue growth stabilizes around 7-8% and gross margin holds near 27-28%. The key assumption is that Coupang can return to positive operating income without sacrificing growth, which would support a modest re-rating from current levels.
CPNG's valuation is mixed. On a price-to-sales basis, the stock appears undervalued, trading at 1.24x versus its historical range of 4.05x to 16.28x. However, on earnings-based metrics, it is overvalued, with a forward PE of 50.95x and a PEG of 7.60x, well above the specialty retail sector average in the mid-to-high teens. The market is pricing in a sharp earnings recovery, with estimated EPS of $0.55 for the forward year versus trailing EPS of $0.00485. If that recovery does not materialize, the stock could derate further. The EV/Sales of 0.69x suggests the market values the business at a modest premium to revenue, but the negative EBITDA makes EV/EBITDA of 34.34x meaningless. Overall, the stock is fairly valued on sales but expensive on earnings, implying the market expects a successful turnaround.
From a risk/reward perspective, CPNG is a high-risk, high-reward proposition. The stock trades at $13.88, just above its 52-week low of $13.86, and offers 69.4% upside to the average analyst target of $23.51. However, the company reported a net loss of $266 million in Q1 2026, with negative EBITDA and free cash flow, and revenue growth has slowed to 7.54%. The biggest downside risk is a break below the 52-week low, which could push the stock toward the analyst low target of $12.00, a 13.5% decline. For risk-tolerant investors with a long-term horizon, the deep value on sales multiples (PS of 1.24x) and dominant market position may justify a small speculative position, but conservative investors should wait for evidence of a profitability turnaround.
CPNG is more suitable for long-term investment than short-term trading. The company is in a turnaround phase, with negative earnings and free cash flow, and the stock is in a severe downtrend, down 56.42% over the past year. Short-term trading is risky due to high volatility (beta of 1.152) and the potential for further downside if the stock breaks below the 52-week low of $13.86. For long-term investors, the deep value on sales multiples and dominant market position could yield substantial returns if management restores profitability. A minimum holding period of 2-3 years is suggested to allow time for the turnaround to materialize and for the market to recognize the value. The lack of a dividend (yield 0%) means returns depend entirely on capital appreciation.